4
Participants
Start Date
October 31, 2014
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC)
Comparison of a cancer treatment containing patient specific irradiated tumor cells mixed with antigen presenting immune cells suspended in an immune system stimulant vs. a cancer treatment containing patient specific immune cells suspended in an immune system stimulant
Autologous PBMCs in GM-CSF (MC)
Comparison of a cancer treatment containing patient specific irradiated tumor cells mixed with antigen presenting immune cells suspended in an immune system stimulant vs. a cancer treatment containing patient specific immune cells suspended in an immune system stimulant
Easton
Philadelphia
Philadelphia
Baltimore
Knoxville
Louisville
Cincinnati
Goshen
Marrero
Dallas
Aurora
Los Angeles
Santa Monica
La Jolla
Irvine
Newport Beach
Orange
Hackensack
Lead Sponsor
Lisata Therapeutics, Inc.
INDUSTRY